Found 0 matching trials
Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917 PHASE2 This study will compare glucose lowering with CS-917 compared to placebo af...
Show More Location
Multiple Locations
Learn More & Join Trial
Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration? PHASE4 Previous data from our clinical trial has demonstrated that the combination...
Show More Location
Dasman Diabetes Institute
Learn More & Join Trial
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes PHASE3 This study will investigate the efficacy and long term safety and tolerabil...
Show More Location
1245.31.10145 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Dapagliflozin Plus Pioglitazone in T1DM PHASE4 Purpose: To examine the effect of addition of combination therapy with dapa...
Show More Status
Active Not Recruiting
Location
University Health System Texas Diabetic Institute
Learn More & Join Trial
Study In People With Type 2 Diabetes PHASE2 This Phase 2 dose-ranging study will evaluate the efficacy, safety and tole...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude PHASE4 Apparent hypoxia-induced insulin insensitivity along with alterations in gl...
Show More Location
US Army Research Institute of Environmental Medicine
Learn More & Join Trial
Bioenergetic Effect of Pioglitazone in CLD-PH PHASE2 The goal of this clinical trial is to learn about the safety and efficacy o...
Show More Location
Emory Healthcare System
Learn More & Join Trial
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis PHASE4 The purpose of this study is to investigate the response to pioglitazone on...
Show More Location
Internal Medicine III, Gastroenterology and Hepatology, Medical University of Vienna
Learn More & Join Trial
MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2) PHASE3 A study to evaluate the efficacy and safety of sitagliptin and pioglitazone...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease N/A Type 2 diabetes mellitus (T2DM) is always accompanied with nonalcoholic fat...
Show More Location
First Affiliated Hospital Xi'an Jiaotong University
Learn More & Join Trial